• 한국간호교육학회지
• /
• 제12권2호
• /
• pp.214-223
• /
• 2006

Purpose: This study is to find the significant symptoms related to bone density, from which a cost-effective nursing diagnosis and intervention can be derived. Method: The research sample was 102 women, the sampling was designed by the researcher's convenience, and the subjects of the sample voluntarily participated in a questionnaire survey and measurements. The questionnaire asked socio-demographics, women' reproductive health symptoms, and the life style of the subject. Osteometer DTX-200 for bone density measure and a ruler for measuring spinal curvature were used. All the data were collected at the two public health clinics in a city in Korea. Result: The subjects' current and completed menopause ages, duration of menopause, degree of spinal curvature, BMI, frequency of parity and etc. showed significant correlations with bone density. However, only the degree of spinal curvature(p<.001, r=-.22) was found to be meaningful as a predicted factor for self diagnosis of bone density level. Conclusions: Since most of the subjects have not recognized the relationships between changes in spinal curvature and lowered bone densities, nurse needs to educate clients to get medical assistance to prevent from further bone density reduction by earlier finding of spinal curvature.

• 대한의용생체공학회:의공학회지
• /
• 제44권4호
• /
• pp.264-274
• /
• 2023

Purpose: The objective is to extract insights that can contribute to the formulation of harmonized international policies and support measures for innovative medical devices and management systems. This study aims to propose effective strategies for future medical device innovation and healthcare delivery. Results: It investigates technological advancements, regulatory approval systems, insurance policies, and successful commercialization cases in South Korea, the United States, and the European Union. In 2018, the FDA implemented insurance coverage for Software as a Medical Device (SaMD) and recognized insurance coverage for Digital Therapeutics (DTx). Germany is a country that ensures permanent reimbursement for healthcare applications since 2020, making it the first country to provide legal health insurance coverage for fostering a digital ecosystem. Conclusion: The findings of this research highlight the importance of cultivating a supportive regulatory and environmental framework to facilitate the adoption of innovative medical devices. Continuous support for research and development (R&D) efforts by companies, along with the validation of clinical effectiveness, is crucial.